IN8BIO, INC. Capital Expenditures
IN8BIO, INC. (INAB) reported Capital Expenditures of $0 for the 9-month period ending 2025-09-30, per its 10-Q filed 2025-11-06.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2025-11-06
- IN8BIO, INC. payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $0.00.
- IN8BIO, INC. payments to acquire property, plant, and equipment for the quarter ending 2025-06-30 was $0.00, a 100.00% decline year-over-year.
- IN8BIO, INC. payments to acquire property, plant, and equipment for the quarter ending 2025-03-31 was $0.00, a 100.00% decline year-over-year.
- IN8BIO, INC. payments to acquire property, plant, and equipment for the quarter ending 2024-09-30 was $0.00.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month |
|---|---|---|---|
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $0.00 derived: sum of 2 quarters · filed 2025-11-06 | $0.00 10-Q · filed 2025-11-06 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $0.00 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-07 | ||
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $21.00K derived: sum of 2 quarters · filed 2025-11-06 | $71.00K 10-Q · filed 2025-11-06 |
| 2024-06-30 | $21.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $71.00K 10-Q · filed 2025-08-07 | |
| 2024-03-31 | $50.00K 10-Q · filed 2025-05-07 | ||
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $36.00K derived: sum of 2 quarters · filed 2024-11-12 | $407.00K 10-Q · filed 2024-11-12 |
| 2023-06-30 | $36.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $407.00K 10-Q · filed 2024-08-08 | |
| 2023-03-31 | $371.00K 10-Q · filed 2024-05-09 | ||
| 2022-09-30 | $39.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $40.00K derived: sum of 2 quarters · filed 2023-11-09 | $48.00K 10-Q · filed 2023-11-09 |
| 2022-06-30 | $1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $9.00K 10-Q · filed 2023-08-10 | |
| 2022-03-31 | $8.00K 10-Q · filed 2023-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| Pluri Inc. (PLUR) | $0.014B | ||
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B |